Perrigo (PRGO) Goodwill & Intangibles (2013 - 2026)
Perrigo's (PRGO) quarterly Goodwill & Intangibles came in at $4.0 billion in Q1 2026, down 32.08% year-on-year from $5.8 billion in Q1 2025, and down 10.01% on a QoQ basis from $4.4 billion in Q4 2025.
Perrigo (PRGO) Goodwill & Intangibles (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Goodwill & Intangibles data on file, last reported at $4.0 billion in Q1 2026.
- On a quarterly basis, Goodwill & Intangibles fell 32.08% year-over-year to $4.0 billion in Q1 2026; TTM through Mar 2026 was $4.0 billion, a 32.08% decrease from a year earlier, with the FY2025 full-year figure at $4.4 billion, down 23.37% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $4.0 billion, down from $4.4 billion in the prior quarter.
- Over the last five years, Goodwill & Intangibles for PRGO reached as high as $6.7 billion in Q3 2022 and fell as low as $3.2 billion in Q2 2023.
- Historically, Goodwill & Intangibles has averaged $5.8 billion across 5 years, with a median of $6.0 billion in 2025.
- Across the five-year window, Goodwill & Intangibles plunged 37.02% in 2023 and surged 101.08% in 2024, its largest moves.
- Year by year, Goodwill & Intangibles stood at $6.7 billion in 2022, then slipped by 3.14% to $6.5 billion in 2023, then fell by 11.77% to $5.7 billion in 2024, then fell by 23.37% to $4.4 billion in 2025, then retreated by 10.01% to $4.0 billion in 2026.
- Per Business Quant data, the three most recent Goodwill & Intangibles figures were $4.0 billion in Q1 2026, $4.4 billion in Q4 2025, and $5.8 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 3.96 Bn |
| Dec 31, 2025 | 4.40 Bn |
| Sep 27, 2025 | 5.76 Bn |
| Jun 28, 2025 | 6.04 Bn |
| Mar 29, 2025 | 5.83 Bn |
| Dec 31, 2024 | 5.74 Bn |
| Sep 28, 2024 | 6.08 Bn |
| Jun 29, 2024 | 6.00 Bn |
| Mar 30, 2024 | 6.36 Bn |
| Dec 31, 2023 | 6.51 Bn |
| Sep 30, 2023 | 6.49 Bn |
| Jul 1, 2023 | 6.63 Bn |
| Apr 1, 2023 | 3.16 Bn |
| Dec 31, 2022 | 6.72 Bn |
| Oct 1, 2022 | 6.43 Bn |
| Jul 2, 2022 | 6.74 Bn |
| Apr 2, 2022 | 5.02 Bn |
| Dec 31, 2021 | 5.15 Bn |
| Oct 2, 2021 | 5.26 Bn |
| Jul 3, 2021 | 5.37 Bn |